There was another study published in 2015, the Morgan study.
Could you explain to us the differences as to methodology or cost analysis? There is a difference in savings between $7.3 billion in the Morgan study and $4.2 billion in the study you presented here today. Could you expound on that?
Many studies contain different figures. Obviously, the methodologies and analyses used aren't necessarily the same. How can we trust one study more than an other?
We would like to be able to quickly move ahead, because we desperately want to save money and offer the best service possible to Canadians when it comes to drug accessibility.